FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139247911> ?p ?o ?g. }

• W3139247911 endingPage "136" @default.
• W3139247911 startingPage "126" @default.
• W3139247911 abstract "The prognosis of patients undergoing transarterial chemoembolization (TACE) is extremely variable, and a confounding factor is that TACE is often repeated several times. We retrospectively evaluated the accuracy of different prognostic scores and staging systems in estimating overall survival (OS) in patients with hepatocellular carcinoma (HCC).An analysis considering prognostic models as time-varying variables was performed, calculating OS from the time of TACE to the time of the subsequent treatment. Total follow-up time for each patient was therefore split into several observation times accounting for each TACE procedure. Values of the likelihood ratio test (LRT) and Akaike information criterion (AIC) were used to compare different systems. Univariable and multivariable analyses were conducted to identify additional factors predictive of OS. We analyzed 1,610 TACE performed in 1,058 patients recorded in the Italian Liver Cancer database from 2008 through 2016.The median OS of the enrolled patients was 41 months. According to LRT χ2 and AIC values based on the time-varying analysis, mHAP-III achieved the best values (41.72 and 4,625.49, respectively, p < 0.0001), indicating the highest predictive performance compared with all other scores (HAP, mHAP-II, ALBI, and pALBI) and staging systems (MELD, ITALICA, CLIP, MESH, MESIAH, JIS, HKLC, and BCLC). In the multivariable Cox proportional hazards model, mHAP-III maintained an independent effect on OS (hazard ratio 1.31, 95% CI: 1.10-1.55, p < 0.0001). Time-varying age, alcoholic etiology, radiologic response to TACE, and performing ablation or surgery after TACE were additional significant variables resulting from the multivariable model.An innovative time-varying analysis revealed that mHAP-III was the most accurate model in predicting OS in patients with HCC undergoing TACE. Other clinical pre- and post-TACE variables were also found to be relevant for this prediction." @default.
• W3139247911 created "2021-03-29" @default.
• W3139247911 creator A5000973050 @default.
• W3139247911 creator A5001054792 @default.
• W3139247911 creator A5003444448 @default.
• W3139247911 creator A5003571894 @default.
• W3139247911 creator A5010487468 @default.
• W3139247911 creator A5014172694 @default.
• W3139247911 creator A5017534922 @default.
• W3139247911 creator A5018377091 @default.
• W3139247911 creator A5021781945 @default.
• W3139247911 creator A5030619209 @default.
• W3139247911 creator A5035805538 @default.
• W3139247911 creator A5037236292 @default.
• W3139247911 creator A5038697021 @default.
• W3139247911 creator A5039554062 @default.
• W3139247911 creator A5041639329 @default.
• W3139247911 creator A5050786916 @default.
• W3139247911 creator A5059921283 @default.
• W3139247911 creator A5060248888 @default.
• W3139247911 creator A5064787053 @default.
• W3139247911 creator A5069315930 @default.
• W3139247911 creator A5073493755 @default.
• W3139247911 creator A5074723888 @default.
• W3139247911 creator A5075952854 @default.
• W3139247911 creator A5076657757 @default.
• W3139247911 creator A5078126497 @default.
• W3139247911 creator A5079697307 @default.
• W3139247911 creator A5084871532 @default.
• W3139247911 creator A5085511371 @default.
• W3139247911 creator A5086787753 @default.
• W3139247911 date "2021-01-01" @default.
• W3139247911 modified "2023-10-18" @default.
• W3139247911 title "Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization" @default.
• W3139247911 cites W1521746876 @default.
• W3139247911 cites W1814665428 @default.
• W3139247911 cites W1902475470 @default.
• W3139247911 cites W1977547491 @default.
• W3139247911 cites W1992523229 @default.
• W3139247911 cites W2028319026 @default.
• W3139247911 cites W2058119212 @default.
• W3139247911 cites W2060123467 @default.
• W3139247911 cites W2061291622 @default.
• W3139247911 cites W2065174039 @default.
• W3139247911 cites W2068331431 @default.
• W3139247911 cites W2079586464 @default.
• W3139247911 cites W2091304504 @default.
• W3139247911 cites W2111640114 @default.
• W3139247911 cites W2119190881 @default.
• W3139247911 cites W2159268982 @default.
• W3139247911 cites W2162322495 @default.
• W3139247911 cites W2186902482 @default.
• W3139247911 cites W2222904843 @default.
• W3139247911 cites W2277004004 @default.
• W3139247911 cites W2281070800 @default.
• W3139247911 cites W2300558317 @default.
• W3139247911 cites W2343903007 @default.
• W3139247911 cites W2413581670 @default.
• W3139247911 cites W2522516475 @default.
• W3139247911 cites W2591170673 @default.
• W3139247911 cites W2591717879 @default.
• W3139247911 cites W2594262320 @default.
• W3139247911 cites W2623680006 @default.
• W3139247911 cites W2761031851 @default.
• W3139247911 cites W2770412892 @default.
• W3139247911 cites W2770527972 @default.
• W3139247911 cites W2890094079 @default.
• W3139247911 cites W2939102712 @default.
• W3139247911 cites W2944054469 @default.
• W3139247911 cites W3006275771 @default.
• W3139247911 cites W4210955410 @default.
• W3139247911 doi "https://doi.org/10.1159/000513404" @default.
• W3139247911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8077424" @default.
• W3139247911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33977089" @default.
• W3139247911 hasPublicationYear "2021" @default.
• W3139247911 type Work @default.
• W3139247911 sameAs 3139247911 @default.
• W3139247911 citedByCount "6" @default.
• W3139247911 countsByYear W31392479112021 @default.
• W3139247911 countsByYear W31392479112022 @default.
• W3139247911 countsByYear W31392479112023 @default.
• W3139247911 crossrefType "journal-article" @default.
• W3139247911 hasAuthorship W3139247911A5000973050 @default.
• W3139247911 hasAuthorship W3139247911A5001054792 @default.
• W3139247911 hasAuthorship W3139247911A5003444448 @default.
• W3139247911 hasAuthorship W3139247911A5003571894 @default.
• W3139247911 hasAuthorship W3139247911A5010487468 @default.
• W3139247911 hasAuthorship W3139247911A5014172694 @default.
• W3139247911 hasAuthorship W3139247911A5017534922 @default.
• W3139247911 hasAuthorship W3139247911A5018377091 @default.
• W3139247911 hasAuthorship W3139247911A5021781945 @default.
• W3139247911 hasAuthorship W3139247911A5030619209 @default.
• W3139247911 hasAuthorship W3139247911A5035805538 @default.
• W3139247911 hasAuthorship W3139247911A5037236292 @default.
• W3139247911 hasAuthorship W3139247911A5038697021 @default.
• W3139247911 hasAuthorship W3139247911A5039554062 @default.
• W3139247911 hasAuthorship W3139247911A5041639329 @default.
• W3139247911 hasAuthorship W3139247911A5050786916 @default.

• next